The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications
Open accessAbstract
MicroRNAs (miRNAs) are noncoding RNAs that have been identified as important posttranscriptional regulators of gene expression. miRNAs production is controlled at multiple levels, including transcriptional and posttranscriptional regulation. Extensive profiling studies have shown that the regulation of mature miRNAs expression plays a causal role in cancer development and progression. miRNAs have been identified to act as tumor suppressors (TS) or as oncogenes based on their modulating effect on the expression of their target genes. Upregulation of oncogenic miRNAs blocks TS genes and leads to tumor formation. In contrast, downregulation of miRNAs with TS function increases the translation of oncogenes. Several miRNAs exhibiting TS properties have been studied. In this review we focus on recent studies on the role of TS miRNAs in cancer cells and the tumor microenvironment (TME). Furthermore, we discuss how TS miRNA impacts the aggressiveness of cancer cells, with focus of the mechanism that regulate its expression. The study of the mechanisms of miRNA regulation in cancer cells and the TME may paved the way to understand its critical role in the development and progression of cancer and is likely to have important clinical implications in a near future. Finally, the potential roles of miRNAs as specific biomarkers for the diagnosis and the prognosis of cancer and the replacement of tumor suppressive miRNAs using miRNA mimics could be promising approaches for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
Liang, Y., Song, X., Li, Y., Chen, B., Zhao, W., Wang, L., Zhang, H., Liu, Y., Han, D., Zhang, N., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01206-5 · Cited by 373
RetractedXu, Y., Zhang, G., Zou, C., Zhang, H., Gong, Z., Wang, W., Ma, G., Jiang, P., & Zhang, W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489651 · Cited by 75
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,373
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Biogenesis of small RNAs in animals
Kim, V. N., Han, J., & Siomi, M. C. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2632 · Cited by 2,814
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005) · Science · doi:10.1126/science.1113329 · Cited by 2,521
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010 · cited 2×
“The global expression analysis of miRNA levels after genotoxic stress that induces the upregulation of p53 has identified that miR-34 family members a, b, and c are strongly upregulated miRNAs (86).”
Backgroundlet-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,910
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
Impaired microRNA processing enhances cellular transformation and tumorigenesis
Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R., & Jacks, T. (2007) · Nature Genetics · doi:10.1038/ng2003 · Cited by 1,463
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352
Roush, S., & Slack, F. J. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.07.007 · Cited by 1,328
Kanellopoulou, C., Muljo, S. A., Kung, A. L., Ganesan, S., Drapkin, R., Jenuwein, T., Livingston, D. M., & Rajewsky, K. (2005) · Genes & Development · doi:10.1101/gad.1248505 · Cited by 1,254
Modulation of microRNA processing by p53
Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., & Miyazono, K. (2009) · Nature · doi:10.1038/nature08199 · Cited by 1,124
A microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078
microRNAs exhibit high frequency genomic alterations in human cancer
Zhang, L., Huang, J., Yang, N., Greshock, J., Megraw, M. S., Giannakakis, A., Liang, S., Naylor, T. L., Barchetti, A., Ward, M. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508889103 · Cited by 1,031
Krebs, A. M., Mitschke, J., Lasierra Losada, M., Schmalhofer, O., Boerries, M., Busch, H., Boettcher, M., Mougiakakos, D., Reichardt, W., Bronsert, P., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3513 · Cited by 975
TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884
Chromosome aberrations in solid tumors
Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73531 · Cited by 753
DICER1 Mutations in Familial Pleuropulmonary Blastoma
Hill, D. A., Ivanovich, J., Priest, J. R., Gurnett, C. A., Dehner, L. P., Desruisseau, D., Jarzembowski, J. A., Wikenheiser-Brokamp, K. A., Suarez, B. K., Whelan, A. J., et al. (2009) · Science · doi:10.1126/science.1174334 · Cited by 751 · cited 1×
“Moreover, it was shown that mutations in human Dicer are recurrent in several cancers (118, 119),, suggested by partial loss of function of the miRNA processing machinery in human tumors.”
BackgroundDicer, Drosha, and Outcomes in Patients with Ovarian Cancer
Merritt, W. M., Lin, Y. G., Han, L. Y., Kamat, A. A., Spannuth, W. A., Schmandt, R., Urbauer, D., Pennacchio, L. A., Cheng, J.-F., Nick, A. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803785 · Cited by 712
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Donehower, L. A., Soussi, T., Korkut, A., Liu, Y., Schultz, A., Cardenas, M., Li, X., Babur, O., Hsu, T.-K., Lichtarge, O., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.001 · Cited by 710
PDL1 Regulation by p53 via miR-34
Cortez, M. A., Ivan, C., Valdecanas, D., Wang, X., Peltier, H. J., Ye, Y., Araujo, L., Carbone, D. P., Shilo, K., Giri, D. K., et al. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv303 · Cited by 683
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Patrawala, L., Brown, D., & Bader, A. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0655 · Cited by 677
A MicroRNA Targeting Dicer for Metastasis Control
Martello, G., Rosato, A., Ferrari, F., Manfrin, A., Cordenonsi, M., Dupont, S., Enzo, E., Guzzardo, V., Rondina, M., Spruce, T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.017 · Cited by 667
MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia
Hua, Z., Lv, Q., Ye, W., Wong, C.-K. A., Cai, G., Gu, D., Ji, Y., Zhao, C., Wang, J., Yang, B. B., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000116 · Cited by 655
Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M., Wyatt, L., Farshid, G., Lim, Y.-Y., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0103 · Cited by 552
Let-7 expression defines two differentiation stages of cancer
Shell, S., Park, S.-M., Radjabi, A. R., Schickel, R., Kistner, E. O., Jewell, D. A., Feig, C., Lengyel, E., & Peter, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704372104 · Cited by 458
Dicer1 functions as a haploinsufficient tumor suppressor
Kumar, M. S., Pester, R. E., Chen, C. Y., Lane, K., Chin, C., Lu, J., Kirsch, D. G., Golub, T. R., & Jacks, T. (2009) · Genes & Development · doi:10.1101/gad.1848209 · Cited by 442
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Su, X., Chakravarti, D., Cho, M. S., Liu, L., Gi, Y. J., Lin, Y.-L., Leung, M. L., El-Naggar, A., Creighton, C. J., Suraokar, M. B., et al. (2010) · Nature · doi:10.1038/nature09459 · Cited by 419
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation
Chang, T.-C., Zeitels, L. R., Hwang, H.-W., Chivukula, R. R., Wentzel, E. A., Dews, M., Jung, J., Gao, P., Dang, C. V., Beer, M. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808300106 · Cited by 407
Chou, J., Lin, J. H., Brenot, A., Kim, J.-W., Provot, S., & Werb, Z. (2013) · Nature Cell Biology · doi:10.1038/ncb2672 · Cited by 373
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
Shen, J., Xia, W., Khotskaya, Y. B., Huo, L., Nakanishi, K., Lim, S.-O., Du, Y., Wang, Y., Chang, W.-C., Chen, C.-H., et al. (2013) · Nature · doi:10.1038/nature12080 · Cited by 356
Yang, N., Kaur, S., Volinia, S., Greshock, J., Lassus, H., Hasegawa, K., Liang, S., Leminen, A., Deng, S., Smith, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1954 · Cited by 352
Up-Regulation of Dicer, a Component of the MicroRNA Machinery, in Prostate Adenocarcinoma
Chiosea, S., Jelezcova, E., Chandran, U., Acquafondata, M., McHale, T., Sobol, R. W., & Dhir, R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060480 · Cited by 347
A Genetic Defect in Exportin-5 Traps Precursor MicroRNAs in the Nucleus of Cancer Cells
Melo, S. A., Moutinho, C., Ropero, S., Calin, G. A., Rossi, S., Spizzo, R., Fernandez, A. F., Davalos, V., Villanueva, A., Montoya, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.007 · Cited by 346
Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer
Mori, M., Triboulet, R., Mohseni, M., Schlegelmilch, K., Shrestha, K., Camargo, F. D., & Gregory, R. I. (2014) · Cell · doi:10.1016/j.cell.2013.12.043 · Cited by 335 · cited 2×
“At higher cell density, YAP is inactivated by exclusion from the cell nucleus, thereby allowing p72 to associate with microprocessor and primiRNAs, resulting in enhanced miRNA biogenesis (82).”
BackgroundSWI/SNF Chromatin Remodeling and Human Malignancies
Masliah-Planchon, J., Bièche, I., Guinebretière, J.-M., Bourdeaut, F., & Delattre, O. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040445 · Cited by 316
Wang, X., Li, J., Dong, K., Lin, F., Long, M., Ouyang, Y., Wei, J., Chen, X., Weng, Y., He, T., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2014.12.003 · Cited by 313
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
Okada, N., Lin, C.-P., Ribeiro, M. C., Biton, A., Lai, G., He, X., Bu, P., Vogel, H., Jablons, D. M., Keller, A. C., et al. (2014) · Genes & Development · doi:10.1101/gad.233585.113 · Cited by 297
Molecular targeted therapy for the treatment of gastric cancer
Xu, W., Yang, Z., & Lu, N. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0276-9 · Cited by 273
DNA methylation and microRNA dysregulation in cancer
Suzuki, H., Maruyama, R., Yamamoto, E., & Kai, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.007 · Cited by 271
H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance
Peng, F., Li, T.-T., Wang, K.-L., Xiao, G.-Q., Wang, J.-H., Zhao, H.-D., Kang, Z.-J., Fan, W.-J., Zhu, L.-L., Li, M., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.438 · Cited by 244
Overexpression of Dicer in Precursor Lesions of Lung Adenocarcinoma
Chiosea, S., Jelezcova, E., Chandran, U., Luo, J., Mantha, G., Sobol, R. W., & Dacic, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3533 · Cited by 241
Chan, Y. C., Khanna, S., Roy, S., & Sen, C. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158790 · Cited by 237
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer
Musumeci, M., Coppola, V, Addario, A., Patrizii, M., Maugeri-Saccà, M., Memeo, L., Colarossi, C., Francescangeli, F., Biffoni, M., Collura, D., et al. (2011) · Oncogene · doi:10.1038/onc.2011.140 · Cited by 236
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
van den Beucken, T., Koch, E., Chu, K., Rupaimoole, R., Prickaerts, P., Adriaens, M., Voncken, J. W., Harris, A. L., Buffa, F. M., Haider, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6203 · Cited by 229
Worringer, K. A., Rand, T. A., Hayashi, Y., Sami, S., Takahashi, K., Tanabe, K., Narita, M., Srivastava, D., & Yamanaka, S. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.001 · Cited by 224
Guo, L., Chen, C., Shi, M., Wang, F., Chen, X., Diao, D., Hu, M., Yu, M., Qian, L., & Guo, N. (2013) · Oncogene · doi:10.1038/onc.2012.573 · Cited by 209
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Cortez, M. A., Valdecanas, D., Zhang, X., Zhan, Y., Bhardwaj, V., Calin, G. A., Komaki, R., Giri, D. K., Quini, C. C., Wolfe, T., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.79 · Cited by 196
MEF2 transcription factors: developmental regulators and emerging cancer genes
Pon, J. R., & Marra, M. A. (2016) · Oncotarget · doi:10.18632/oncotarget.6223 · Cited by 196
Lim, Y., Wright, J. A., Attema, J. L., Gregory, P. A., Bert, A. G., Smith, E., Thomas, D., Drew, P. A., Khew-Goodall, Y., & Goodall, G. J. (2013) · Journal of Cell Science · doi:10.1242/jcs.122275 · Cited by 191
Pekarsky, Y., & Croce, C. M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.87 · Cited by 186
Epigenetic regulation of miR‐34b and miR‐129 expression in gastric cancer
Tsai, K., Wu, C., Hu, L., Li, S., Liao, Y., Lai, C., Kao, H., Fang, W., Huang, K., Chan, W., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25919 · Cited by 183
Yu, C.-C. (2011) · Oncology Reports · doi:10.3892/or.2011.1360 · Cited by 169
20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2731 · Cited by 168
Hypoxia-regulated microRNAs in human cancer
Shen, G., Li, X., Jia, Y.-F., Piazza, G. A., & Xi, Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.195 · Cited by 164
Cicatiello, L., Mutarelli, M., Grober, O. M. V., Paris, O., Ferraro, L., Ravo, M., Tarallo, R., Luo, S., Schroth, G. P., Seifert, M., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090837 · Cited by 161
MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin
Zhang, N., Wang, X., Huo, Q., Sun, M., Cai, C., Liu, Z., Hu, G., & Yang, Q. (2014) · Oncogene · doi:10.1038/onc.2013.286 · Cited by 161
MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer
Yu, S.-J., Hu, J.-Y., Kuang, X.-Y., Luo, J.-M., Hou, Y.-F., Di, G.-H., Wu, J., Shen, Z.-Z., Song, H.-Y., & Shao, Z.-M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1959 · Cited by 159
Stahlhut, C. E., & Slack, F. J. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1003008 · Cited by 155
ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5
Sun, H., Cui, R., Zhou, J., Teng, K., Hsiao, Y., Nakanishi, K., Fassan, M., Luo, Z., Shi, G., Tili, E., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.001 · Cited by 154
The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer
Peng, Y., Zhang, X., Feng, X., Fan, X., & Jin, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.12923 · Cited by 149 · cited 1×
“Many miRNAs as the well-studied miR200 were shown to target b-catenin (29).”
BackgroundTitle, A. C., Hong, S., Pires, N. D., Hasenöhrl, L., Godbersen, S., Stokar‐Regenscheit, N., Bartel, D. P., & Stoffel, M. (2018) · Nature Communications · doi:10.1038/s41467-018-07130-z · Cited by 147
Li, B., Lu, W., Qu, J., Ye, L., Du, G., & Wan, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27111 · Cited by 142
Mechanisms and role of microRNA deregulation in cancer onset and progression
Palmero, E. I., Campos, S. G. P., Campos, M., Nogueira-de-Souza, N. C., Guerreiro, I. D. C., Carvalho, A. L., & Marques, M. M. C. (2011) · Genetics and Molecular Biology · doi:10.1590/s1415-47572011000300001 · Cited by 140
miR-181a promotes osteoblastic differentiation through repression of TGF-β signaling molecules.
Bhushan, R., Grünhagen, J., Becker, J. L., Robinson, P., Ott, C., & Knaus, P. (2013) · International Journal of Biochemistry and Cell Biology · doi:10.1016/j.biocel.2012.12.008 · Cited by 134
Repression of VEGFA by CA‐rich element‐binding microRNAs is modulated by hnRNP L
Jafarifar, F., Yao, P., Eswarappa, S. M., & Fox, P. L. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.38 · Cited by 129
Aberrant DNA methylation in contrast with mutations
Ushijima, T., & Asada, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01434.x · Cited by 125
Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity
Gurtner, A., Falcone, E., Garibaldi, F., & Piaggio, G. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0319-x · Cited by 114
Ramola, S., Belwal, T., Li, C., Wang, Y. Y., Lu, H. H., Yang, S., & Zhou, C. H. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.136171 · Cited by 111
Tan, S. H., Ding, K., Li, R. Q., Zhang, W., Li, G., Kong, X., Qian, P., Lobie, P. E., & Zhu, T. (2014) · Breast Cancer Research · doi:10.1186/bcr3644 · Cited by 110
A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness
di Gennaro, A., Damiano, V., Brisotto, G., Armellin, M., Perin, T., Zucchetto, A., Guardascione, M., Spaink, H. P., Doglioni, C., Snaar-Jagalska, E. B., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0103-x · Cited by 110
Lee, K., Lin, F., Hsu, T., Lin, J., Guo, J.-H., Tsai, C.-H., Lee, Y., Lee, Y., Chen, C., Hsiao, M., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.06.001 · Cited by 107
Mohammadi‐Yeganeh, S., Paryan, M., Arefian, E., Vasei, M., Ghanbarian, H., Mahdian, R., Karimipoor, M., & Soleimani, M. (2016) · Tumor Biology · doi:10.1007/s13277-015-4513-9 · Cited by 101
Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression
Xing, Y., Ruan, G., Ni, H., Qin, H., Chen, S., Gu, X., Shang, J., Zhou, Y., Xi, T., & Zheng, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624725 · Cited by 101
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
Rupaimoole, R., Ivan, C., Yang, D., Gharpure, K. M., Wu, S. Y., Pecot, C. V., Previs, R. A., Nagaraja, A. S., Armaiz-Peña, G. N., McGuire, M. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.492 · Cited by 95
Dummer, R., DAUD, A. I., Puzanov, I. J., Hamid, O., Schadendorf, D., Robert, C., Schachter, J., Pavlick, A. C., Gonzalez, R. C., Hodi, F. S., et al. (2015) · Journal of Translational Medicine · doi:10.1186/1479-5876-13-s1-o5 · Cited by 94
Gurtner, A., Starace, G., Norelli, G., Piaggio, G., Sacchi, A., & Bossi, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094813 · Cited by 92
Ramírez-Moya, J., Wert-Lamas, L., Riesco‐Eizaguirre, G., & Santisteban, P. (2019) · Oncogene · doi:10.1038/s41388-019-0804-8 · Cited by 91
Ma, F., Song, H., Guo, B., Zhang, Y., Zheng, Y., Lin, C., Wu, Y., Guan, G., Sha, R., Zhou, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3744 · Cited by 88
Bottani, M., Banfi, G., & Lombardi, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101661 · Cited by 85
Anaplastic sarcomas of the kidney are characterized by DICER1 mutations
Wu, M. K., Vujanic, G. M., Fahiminiya, S., Watanabe, N., Thorner, P. S., O’Sullivan, M. J., Fabian, M. R., & Foulkes, W. D. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.100 · Cited by 84
Vedanayagam, J., Chatila, W. K., Aksoy, B. A., Majumdar, S., Skanderup, A. J., Demir, E., Schultz, N. D., Sander, C., & Lai, E. C. (2019) · Nature Communications · doi:10.1038/s41467-019-11610-1 · Cited by 82
Thibault, P. A., Huys, A., Amador‐Cañizares, Y., Gailius, J. E., Pinel, D. E., & Wilson, J. A. (2015) · Journal of Virology · doi:10.1128/jvi.03631-14 · Cited by 80
The Oncogenic Roles of DICER1 RNase IIIb Domain Mutations in Ovarian Sertoli-Leydig Cell Tumors
Wang, Y., Chen, J., Yang, W., Mo, F., Senz, J., Yap, D., Anglesio, M. S., Gilks, C. B., Morin, G. B., & Huntsman, D. D. (2015) · Neoplasia · doi:10.1016/j.neo.2015.08.003 · Cited by 79
Bean, G. R., Anderson, J. A., Sangoi, A. R., Krings, G., & Garg, K. (2018) · Modern Pathology · doi:10.1038/s41379-018-0132-5 · Cited by 76
Feng, H., Ge, F., Du, L., Zhang, Z., & Liu, D. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14404 · Cited by 75
Li, P., Sun, Y., & Liu, Q. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445553 · Cited by 73
Tang, Z., Ow, G. S., Thiery, J. P., Ivshina, A. V., & Kuznetsov, V. A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28371 · Cited by 72
MiR-200 family and cancer: From a meta-analysis view
Huang, G., Sun, J., Lü, Y., Liu, Y., Cao, H., Zhang, H., & Calin, G. A. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.09.005 · Cited by 72
Allegra, D., Bilan, V., Garding, A., Döhner, H., Stilgenbauer, S., Kuchenbauer, F., Mertens, D., & Zucknick, M. (2013) · Leukemia · doi:10.1038/leu.2013.246 · Cited by 71
Czubak, K., Lewandowska, M. A., Klonowska, K., Roszkowski, K., Kowalewski, J., Figlerowicz, M., & Kozłowski, P. (2015) · Oncotarget · doi:10.18632/oncotarget.4351 · Cited by 70
miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells
Lee, Y.-M., Lee, J.-Y., Ho, C., Hong, Q.-S., Yu, S., Tzeng, C., Yang, P., & Chen, H. (2011) · Breast Cancer Research · doi:10.1186/bcr3059 · Cited by 69
MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia
Rassenti, L. Z., Balatti, V., Ghia, E. M., Palamarchuk, A., Tomasello, L., Fadda, P., Pekarsky, Y., Widhopf, G. F., Kipps, T. J., & Croce, C. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708264114 · Cited by 68
Meng, X., Sun, W., Yu, J., Zhou, Y., Gu, Y., Han, J., Zhou, L., Jiang, X., & Wang, C. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.018 · Cited by 66
Epigenetic inactivation of the MIR34B/C in multiple myeloma
Wong, K. Y., Yim, R., So, C. C., Jin, D., Liang, R. H. S., & Chim, C. S. (2011) · Blood · doi:10.1182/blood-2011-06-361022 · Cited by 64
Guo, M., Zhao, X., Yuan, X., Jiang, J., & Li, P. (2017) · Oncotarget · doi:10.18632/oncotarget.15999 · Cited by 63
B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
Ma, J., Ma, P., Zhao, C., Xue, X., Han, H., Liu, C., Tao, H., Xiu, W., Cai, J., & Zhang, M. (2016) · Oncotarget · doi:10.18632/oncotarget.8784 · Cited by 62
Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer
Torres, A., Torres, K., Paszkowski, T., Jodłowska‐Jędrych, B., Radomański, T., Książek, A., & Maciejewski, R. (2011) · Tumor Biology · doi:10.1007/s13277-011-0179-0 · Cited by 61
MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3′UTR
Wang, Y., Cui, M., Sun, B., Liu, F.-B., Zhang, X., & Ye, L. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.59 · Cited by 61
A Curated Database of miRNA Mediated Feed-Forward Loops Involving MYC as Master Regulator
Baroudi, M. E., Corà, D., Bosia, C., Osella, M., & Caselle, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014742 · Cited by 60
Han, J., Yu, J., Dai, Y., Li, J., Guo, M., Song, J.-Z., & Zhou, X. (2018) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2018.3399 · Cited by 60
lncRNA LINC00460 promoted colorectal cancer cells metastasis via miR-939-5p sponging
Zhang, Y., Liu, X., Li, Q., & Zhang, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s192452 · Cited by 60
Li, J., Pu, W., Sun, H., Zhou, J., Fan, X., Zheng, Y., He, J., Liu, X., Xia, Z., Liu, L., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0065-z · Cited by 54
Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis
Chen, J., Wang, Y., McMonechy, M. K., Anglesio, M. S., Yang, W., Senz, J., Maines‐Bandiera, S., Rosner, J., Trigo‐Gonzalez, G., Cheng, S. G., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4569 · Cited by 53
Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex
Garibaldi, F., Falcone, E., Trisciuoglio, D., Colombo, T., Lisek, K., Walerych, D., Sal, G. D., Paci, P., Bossi, G., Piaggio, G., et al. (2016) · Oncogene · doi:10.1038/onc.2016.51 · Cited by 53
Galka-Marciniak, P., Urbanek-Trzeciak, M. O., Nawrocka, P. M., Dutkiewicz, A., Giefing, M., Lewandowska, M. A., & Kozłowski, P. (2019) · Cancers · doi:10.3390/cancers11060793 · Cited by 53
Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis
Purvis, I. J., Avilala, J., Guda, M. R., Venkataraman, S., Vibhakar, R., Tsung, A. J., Velpula, K. K., & Asuthkar, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081158 · Cited by 53
Jiang, F., He, Y., Wang, H. H., Zhang, H., Zhang, J., Yan, X., Wang, X.-J., Che, Q., Ke, J., Chen, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6350 · Cited by 52
A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis
Chen, Y., Zhou, Y., Han, F., Zhao, Y.-Y., Tu, M., Wang, Y., Huang, C., Fan, S., Chen, P., Yao, X., et al. (2020) · Theranostics · doi:10.7150/thno.44877 · Cited by 52
Liu, D., Chen, C., Cui, M., & Zhang, H. (2021) · Cancer Medicine · doi:10.1002/cam4.3840 · Cited by 48
Kato, N., Kusumi, T., Kamataki, A., Tsunoda, R., Fukase, M., & Kurose, A. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.09.005 · Cited by 46
Li, X., Chen, J., Zhou, L., Wang, C., Wen, X., Jia, L., Cui, J., Hoffman, A. R., Hu, J., & Li, W. (2019) · PubMed · Cited by 43
Mesri, M., Birse, C., Heidbrink, J. L., McKinnon, K., Brand, E., Bermingham, C. L., Feild, B. J., FitzHugh, W., He, T., Ruben, S. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078885 · Cited by 42
Yu, J., Wang, R., Chen, J., Wu, J., Dang, Z., Zhang, Q., & Li, B. (2017) · Medical Science Monitor · doi:10.12659/msm.898449 · Cited by 42
Tong, D., Zhang, J., Wang, X., Li, Q., Liu, L., Lu, A., Guo, B., Yang, J., Ni, L., Qin, H., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-00281-z · Cited by 38
The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma
Ghafouri‐Fard, S., Gholipour, M., Hussen, B. M., & Taheri, M. N. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.649107 · Cited by 36
Insights into Wild-Type and Mutant p53 Functions Provided by Genetically Engineered Mice
Donehower, L. A. (2014) · Human Mutation · doi:10.1002/humu.22507 · Cited by 33
Yuan, L., Bing, Z., Yan, P., Li, R., Wang, C., Sun, X., Yang, J., Shi, X., Zhang, Y., & Yang, K. (2019) · Gene · doi:10.1016/j.gene.2019.144025 · Cited by 27
miR-133a-5p suppresses gastric cancer through TCF4 down-regulation
He, M., Wan, J.-F., Zeng, H.-F., Tang, Y.-Y., & He, M. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-20-418 · Cited by 24
Ll, Z., Fj, X., Ch, T., Wr, X., Xs, D., & Liang, J. (2017) · PubMed · Cited by 23
Roshini, A., Lee, J., Bayarsaikhan, D., Kwak, P., Son, M., Byun, K., Salekdeh, G. H., & Lee, B. (2017) · Oncotarget · doi:10.18632/oncotarget.23703 · Cited by 22
Zhou, H., Shi, P., Jia, X., & Xue, Q. (2021) · Oncology Letters · doi:10.3892/ol.2021.12802 · Cited by 22
Liu, Y., Yang, S., Wang, F., Zhou, Z., Xu, W., Xie, J., Qiao, L., & Gu, Y. (2021) · Oncology Letters · doi:10.3892/ol.2021.12795 · Cited by 22
Sai, X., Qin, C., Yan, W. S., Zhao, Y., & Bian, T. (2020) · Journal of International Medical Research · doi:10.1177/0300060520923522 · Cited by 20
The Prognostic Value of the MiR-200 Family in Colorectal Cancer: A Meta-analysis with 1882 Patients
Yu, C., Wan, H., Shan, R., Wen, W., Li, J., Luo, D., & Wan, R. (2019) · Journal of Cancer · doi:10.7150/jca.27529 · Cited by 19
FRZBas a key molecule in abdominal aortic aneurysm progression affecting vascular integrity
Oh, C., Ko, Y., Park, J. J., Heo, H. J., Kang, J., Kwon, E. J., Kang, J. W., Lee, Y., Myung, K., Kang, J. M., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20203204 · Cited by 17
Chen, L., Xu, X., Wen, X., Xu, S., Wang, L., Lu, W., Jiang, M., Huang, J., Yang, D., Wang, J., et al. (2019) · Cancer Science · doi:10.1111/cas.14085 · Cited by 16
Peinado, P., Andrades, Á., Martorell‐Marugán, J., Haswell, J. R., Slack, F. J., Carmona‐Sáez, P., & Medina, P. P. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab187 · Cited by 8
Metadata
- Authors
- Otmani, K., & Lewalle, P.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2021-10-15
- Volume
- 11
- Pages
- 708765-708765
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3205473828
- Cited by
- 279
- References
- 147
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.